KRAS and non-small cell lung carcinoma: Similarly, some studies had reported that BTK might serve as a downstream effector in KRAS- and EGFR-activated signals in NSCLC, which might be explained by the existence of the distinct isoform of BTK in NSCLC (25, 26).